Sovereign wealth funds investing in healthcare and life sciences in Asia
This page lists 18 sovereign wealth funds investing in healthcare and life sciences in Asia. The list includes reserve investment corporations, state holding companies, strategic development funds, pension reserve funds, and a savings fund. Featured institutions include China Investment Corporation, GIC Private Limited, Temasek Holdings, and Japan Investment Corporation.
The 18 funds
| # | Fund | Country | Reported size | In US dollars | Type | Our transparency score |
|---|---|---|---|---|---|---|
| 1 | China Investment Corporation | China | USD 1,567B, as of December 9, 2025[1][2] | USD 1.57T | Reserve investment corporation | 8 of 10 |
| 2 | GIC Private Limited | Singapore | About USD 1.16T Estimate, as of March 31, 2026[3] | USD 1.16T | Reserve investment corporation | 7 of 10 |
| 3 | Hong Kong Monetary Authority Exchange Fund | Hong Kong SAR, China | HKD 4,463.6B, as of June 30, 2026[4] | USD 572.0B | Reserve investment corporation | 8 of 10 |
| 4 | National Council for Social Security Fund (NSSF) | China | RMB 3,808B, as of December 31, 2025[5][6] | USD 544.0B | Pension reserve fund | 8 of 10 |
| 5 | Temasek Holdings | Singapore | S$518B, as of July 8, 2026[7][8] | USD 401.0B | State holding company | 10 of 10 |
| 6 | Korea Investment Corporation | South Korea | USD 232.0B, as of December 31, 2025[9] | USD 232.0B | Reserve investment corporation | 8.5 of 10 |
| 7 | Permodalan Nasional Berhad (PNB) | Malaysia | RM365.3B, as of December 31, 2025[10][11] | USD 90.1B | State holding company | 8.5 of 10 |
| 8 | Samruk-Kazyna JSC | Kazakhstan | KZT 44.2T, as of December 31, 2025[12] | USD 87.5B | State holding company | 8.5 of 10 |
| 9 | National Development Fund (Taiwan) | Taiwan | NT$2,098.5B, as of December 31, 2024[13] | USD 64.0B | Strategic development fund | 8 of 10 |
| 10 | Khazanah Nasional Berhad | Malaysia | RM156B, as of July 9, 2026[14][15][16] | USD 38.4B | State holding company | 9 of 10 |
| 11 | Hong Kong Future Fund | Hong Kong SAR, China | HK$235.1B, as of January 28, 2026[17] | USD 30.2B | Savings and future generations fund | 4 of 10 |
| 12 | Japan Investment Corporation (JIC) | Japan | JPY 2.60T, as of March 31, 2026[18] | USD 16.6B | Strategic development fund | 6.5 of 10 |
| 13 | Tamilnadu Industrial Development Corporation Ltd (TIDCO) | India | INR 103,607 crore, as of December 31, 2025[19][20] | USD 11.5B | State holding company | 5 of 10 |
| 14 | Hong Kong Investment Corporation (HKIC) | Hong Kong SAR, China | HK$62B, as of October 5, 2026[21] | USD 8.0B | Strategic development fund | 6 of 10 |
| 15 | Indonesia Investment Authority | Indonesia | Rp111.0tn, as of December 31, 2025[22][23] | USD 6.6B | Strategic development fund | 9 of 10 |
| 16 | National Investment and Infrastructure Fund (NIIF), India | India | USD 5B+, as of June 29, 2026[24] | USD 5.0B | Strategic development fund | 6 of 10 |
| 17 | Armed Forces Fund Board | Malaysia | RM13.36B, as of March 12, 2026[25] | USD 3.3B | Pension reserve fund | 5.5 of 10 |
| 18 | State Capital Investment Corporation | Vietnam | VND 72,474bn total assets (end 2025), as of July 1, 2026[26][11] | USD 2.8B | State holding company | 8.5 of 10 |
Patterns in this list
- The funds are based across Asia, including China, Singapore, Hong Kong, South Korea, Malaysia, Kazakhstan, Taiwan, Japan, India, Indonesia, and Vietnam.
- Fund structures include reserve investment corporations, state holding companies, strategic development funds, pension reserve funds, and savings funds.
- Investment approaches range from direct stakes and joint ventures to external manager mandates, venture fund commitments, and co-investments.
How we built this list
This list includes every operating fund in our 231 fund profiles that matches on the focus sectors field and is based in Asia. Funds are ordered by their latest reported size in US dollars, shown in its own column next to the size in the currency each fund reports. Each profile shows the document and date behind every figure, and estimates carry an Estimate label.
See all funds in the region: Asia sovereign wealth funds
Related lists
- Sovereign wealth funds investing in financial services in Asia
- Sovereign wealth funds investing in infrastructure and utilities in Asia
- Sovereign wealth funds investing in real estate in Asia
- Sovereign wealth funds investing in technology in Asia
- Sovereign wealth funds investing in industrials and manufacturing in Asia
Frequently asked questions
Which Asian sovereign funds allocate to life sciences through venture capital and private equity funds?
Japan Investment Corporation commits capital to private general partners, and National Development Fund in Taiwan has backed 117 venture capital funds. Hong Kong Investment Corporation, Temasek Holdings, and National Investment and Infrastructure Fund also use private equity or venture capital formats.
Do these sovereign wealth funds co-invest in healthcare alongside external partners?
Yes. GIC Private Limited, Temasek Holdings, Indonesia Investment Authority, and Permodalan Nasional Berhad regularly co-invest with general partners and operating companies. National Investment and Infrastructure Fund and China Investment Corporation also take direct co-investment positions.
Which state holding companies on this list hold direct assets in pharmaceuticals and healthcare?
State Capital Investment Corporation in Vietnam, Armed Forces Fund Board and Permodalan Nasional Berhad in Malaysia, and Tamilnadu Industrial Development Corporation Ltd in India all hold direct interests in pharmaceuticals or healthcare companies.
Sources
- CIC, Annual Report 2024, as of December 9, 2025
- CIC, release on the 2024 annual report (Chinese), as of December 9, 2025
- Reuters, GIC results and hedge fund plan, 23 July 2026, as of July 24, 2026
- HKMA, Exchange Fund position at end of June 2026, press release, as of July 28, 2026
- Securities Times, NSSF annual report 2025 figures (Chinese), as of September 2, 2026
- ECB reference rate via Frankfurter, USD/CNY on 31 December 2025, as of December 31, 2025
- Temasek, Temasek Review 2026 press release, 8 July 2026, as of July 8, 2026
- Temasek Review 2026, Performance and portfolio, as of March 31, 2026
- KIC Annual Report 2025, performance overview, as of December 31, 2025
- PNB, Integrated Annual Report 2025, as of December 31, 2025
- Currency API, US dollar rates at 31 December 2025, as of December 31, 2025
- Samruk-Kazyna, Annual Report 2025 with audited IFRS statements, as of December 31, 2025
- National Development Fund, annual report 2024 (Chinese), as of December 31, 2024
- Khazanah, Laporan Khazanah 2025 (Malay), as of July 9, 2026
- Khazanah, Annual Review 2026 presentation, as of February 10, 2026
- Frankfurter, USD to MYR reference rate for 31 December 2025, as of December 31, 2025
- HKMA, Exchange Fund results for 2025, 28 January 2026, as of January 28, 2026
- JIC, investment record, as of March 31, 2026
- CARE Ratings, TIDCO rating rationale, April 2026, as of April 13, 2026
- Frankfurter, USD to INR rate on 31 December 2025, as of December 31, 2025
- Hong Kong Investment Corporation, Home, as of October 5, 2026
- INA, Annual Report 2025, as of December 31, 2025
- Frankfurter (ECB reference rates), 31 December 2025, as of December 31, 2025
- NIIF, Government approves additional INR 30,000 crore allocation, as of June 29, 2026
- The Edge Malaysia, LTAT FY2025 dividend and liquid assets, as of March 12, 2026
- Nguoi Quan Sat, inside SCIC capital and dividends, as of July 1, 2026
Talk to Richard
Richard C. Wilson founded the Family Office Club and publishes SovereignWealthFunds.com. If you are a fund manager, capital raiser or family office and want to talk through sovereign wealth funds investing in healthcare and life sciences in Asia, reach out to him directly.
- Email: richard@familyoffices.com
- Text: (808) 600-9260
- WhatsApp: (808) 600-9260
Disclaimer
Informational only. SovereignWealthFunds.com is an independent public-source reference. It is not affiliated with or endorsed by any fund named on it, and it is not investment, legal or tax advice. Figures are as of the dates shown next to them and may have changed; please read each fund's official pages, linked on its profile. To report an error, use the contact page. Copyright SovereignWealthFunds.com. All rights reserved.
